Genzyme Wins Restrictions On Generic Arthritis Drug Price
Genzyme Corp. has won a preliminary injunction in its infringement suit against Seikagaku Corp. over osteoarthritis knee pain treatment Synvisc-One, setting a minimum price at which the Japanese pharmaceutical maker can...To view the full article, register now.
Already a subscriber? Click here to view full article